Apremilast for the off-label treatment of lichenoid and interface dermatoses.
Publication
, Journal Article
Ravichandran, S; Kheterpal, MK
Published in: J Am Acad Dermatol
November 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
November 2020
Volume
83
Issue
5
Start / End Page
1489 / 1491
Location
United States
Related Subject Headings
- Young Adult
- Thalidomide
- Retrospective Studies
- Phosphodiesterase 4 Inhibitors
- Off-Label Use
- Middle Aged
- Lichenoid Eruptions
- Humans
- Female
- Dermatology & Venereal Diseases
Citation
APA
Chicago
ICMJE
MLA
NLM
Ravichandran, S., & Kheterpal, M. K. (2020). Apremilast for the off-label treatment of lichenoid and interface dermatoses. J Am Acad Dermatol, 83(5), 1489–1491. https://doi.org/10.1016/j.jaad.2020.05.112
Ravichandran, Surya, and Meenal K. Kheterpal. “Apremilast for the off-label treatment of lichenoid and interface dermatoses.” J Am Acad Dermatol 83, no. 5 (November 2020): 1489–91. https://doi.org/10.1016/j.jaad.2020.05.112.
Ravichandran S, Kheterpal MK. Apremilast for the off-label treatment of lichenoid and interface dermatoses. J Am Acad Dermatol. 2020 Nov;83(5):1489–91.
Ravichandran, Surya, and Meenal K. Kheterpal. “Apremilast for the off-label treatment of lichenoid and interface dermatoses.” J Am Acad Dermatol, vol. 83, no. 5, Nov. 2020, pp. 1489–91. Pubmed, doi:10.1016/j.jaad.2020.05.112.
Ravichandran S, Kheterpal MK. Apremilast for the off-label treatment of lichenoid and interface dermatoses. J Am Acad Dermatol. 2020 Nov;83(5):1489–1491.
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
November 2020
Volume
83
Issue
5
Start / End Page
1489 / 1491
Location
United States
Related Subject Headings
- Young Adult
- Thalidomide
- Retrospective Studies
- Phosphodiesterase 4 Inhibitors
- Off-Label Use
- Middle Aged
- Lichenoid Eruptions
- Humans
- Female
- Dermatology & Venereal Diseases